A Study To Assess The Effect Of Linezolid On QTc Interval

NCT00795145 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Placebo
DRUG: Linezolid 900 mg
DRUG: Linezolid 1200 mg
DRUG: Placebo
DRUG: Linezolid 600 mg
DRUG: Linezolid 1200 mg
DRUG: Moxifloxacin 400 mg

Sponsor

Pfizer